Mutant TP53 traps FOXP3, disrupting PD-L1 control and fueling immune evasion in lung cancer
Immune checkpoint inhibitors have transformed the treatment of lung adenocarcinoma, yet they fail in nearly half of the patients who ...
Immune checkpoint inhibitors have transformed the treatment of lung adenocarcinoma, yet they fail in nearly half of the patients who ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine